Natco Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 1,552.00 123.80  | 8.67% 80.85% 45.50 4,741.12
NSE Price: Mar 03 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Mar 03 1,552.00 123.80 8.67% 1,443.95 1,428.20 334,874 1,443.90 - 1,569.90
BSE Mar 03 1,553.15 126.60 8.87% 1,446.00 1,426.55 30,847 1,445.60 - 1,570.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
6M Average Volume: 59,060 P/B: 5.74 NSE Code: NATCOPHARM
52-Week Range: R 650.00 - 1,590.00 Dividend Yield: 0.35% BSE Code: 524816
TTM EPS: R 31.35 Book Value: R 248.42 Face Value: R 10
Price Graph
  • Divi's Laboratories (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Natco Pharma* -6.67 4.61 1.05 68.95 73.32 63.24 26.46
S&P BSE Mid Cap 6.84 2.91 5.54 71.00 20.34 10.77 13.17
S&P BSE Healthcare 11.38 5.67 8.09 53.35 36.71 26.65 19.97
Company's return has been calculated on basis of NSE's price.
As on Mar 03, 2015
*As on Mar 02, 2015
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 11.86 17.14 10.75
Net Profit 48.91 23.64 16.69
EPS 35.60 17.78 14.65
Book Value 29.06 20.57 19.03
Average
Operating Margin 26.53 24.58 23.09
Net Margin 12.98 11.25 11.06
Return on Networth 15.58 14.27 15.12
Return on Investment 18.02 16.60 16.90
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -10.84 -3.88 6.34
Operating Profit -11.51 -0.53 16.26
Net Profit -56.27 -50.24 -46.41
EPS -55.91 - -40.59
TTM
Revenue -0.97 11.91 9.41
Operating Profit -0.13 20.51 13.67
Net Profit -11.85 26.84 4.73
EPS 15.88 772.52 333.47
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Natco Pharma 4,741.12 808.45 102.60 12.35 15.58 5.74 45.50
Divi's Laboratories 23,406.36 3,007.52 811.21 26.37 28.31 6.43 28.85
Glenmark Pharma. 21,367.16 2,641.04 488.76 18.10 18.99 6.58 42.08
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Oct 13, 2014 Linga Rao Donthineni  Sell Market 2,500 1,393.55 34.84
Jun 30, 2014 NATCO Group Employees Welfare Trust  Sell Off Market 8,846 1,004.75 88.88
Jun 19, 2014 Neelima Nannapaneni Trust  Buy Market 360,000 1,031.95 3,715.02
Mar 04, 2014 NATCO Group Employee Welfare Trust  Sell Off Market 13,961 857.30 119.69
Feb 25, 2014 NATCO Gruop Employees Welfare Trust  Sell Off Market 10,443 795.25 83.05
Fund Houses which are invested in the stock
Fund Dec-14 Sep-14 Jun-14 Mar-14 Dec-13
ICICI Prudential Mutual Fund 3.326 3.443 - - 4.995
SBI Mutual Fund 1.978 0.759 2.120 2.701 2.731
Birla Sun Life Mutual Fund 0.624 0.670 0.660 - -
L&T Mutual Fund 0.575 0.759 0.854 0.932 1.400
Mirae Asset Mutual Fund 0.424 0.388 0.115 - -
UTI Mutual Fund 0.392 0.372 0.393 0.254 0.240
Franklin Templeton Mutual Fund 0.122 0.228 0.228 0.183 0.183
Edelweiss Mutual Fund 0.008 - - - -
Sahara Mutual Fund 0.005 0.006 - - 0.007
Shriram Mutual Fund 0.003 0.004 0.002 0.004 0.004
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Natco Pharma Ltd.

Address: Natco House, Road No 2, Banjara Hills, Hyderabad, Andhra Pradesh - 500033 | Phone: +91-40- 23547532 | Fax: +91-40- 23548243

Email: investors@natcophrma.co.in

Website: www.natcopharma.co.in

Registrar & Transfer Agent: Venture Capital & Corporate Investments Ltd

Address: 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad | Phone: 91-40-23818475/6 | Fax: 91-40-23868024

Email: info@vccilindia.com

Related Stocks
Natco Pharma ₹1,552.00 +8.67%
Alembic Pharmaceuticals ₹422.25 +3.43%
Biocon ₹435.05 -1.01%
Divi's Laboratories ₹1,773.00 +0.49%
Glenmark Pharma. ₹799.35 +1.59%
Ipca Laboratories ₹677.10 +1.76%
Piramal Enterprises ₹898.80 +1.00%
Sanofi India ₹3,393.15 -0.12%
Torrent Pharmaceuticals ₹1,081.45 +2.15%
Wockhardt ₹1,665.70 +0.32%
As on Mar 03